Atomwise

Atomwise is an artificial intelligence company focused on using deep learning for structure-based drug design and discovery. The company applies convolutional neural networks to predict binding affinity between small molecules and protein targets, enabling faster and more efficient virtual screening for pharmaceutical and biotech partners.